Clinical Trial

Implementing Polygenic Risk Scores for Breast Cancer Prevention: a Feasibility Study

Study acronym: MIG
Recruiting
View on ClinicalTrials.gov →
Summary
This single-arm interventional feasibility study will evaluate whether integrating polygenic risk scores (PRS) into the CanRisk model can improve breast cancer risk prediction and personalized prevention in women at risk of breast cancer. The study will assess the organizational feasibility, patient acceptance, emotional impact and satisfaction of an integrated pathway combining PRS testing with standard genetic counseling and other risk factors at Fondazione Policlinico Universitario Agostino Gemelli IRCCS.
Protocol Amendment History 5 changes
critical Recruitment opened 2026-08-01
critical Primary endpoint(s) modified 2026-08-01
notable Sponsor changed: Boccia Stefania -> Catholic University of the Sacred Heart 2026-08-01
notable Primary completion pushed: 2026-03-31 -> 2026-09-30 2026-08-01
minor Completion pushed: 2026-05-30 -> 2026-11-30 2026-08-01
Trial Details
NCT Number NCT06922708
Lead Sponsor Catholic University of the Sacred Heart
Conditions Breast Cancer
Enrollment 100 participants
Start Date 2025-06-06
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-03